Savant Capital, LLC Edwards Lifesciences Corp Transaction History

Savant Capital, LLC

  • $12.3 Billion
  • Q4 2024

A detailed history of Savant Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Savant Capital, LLC holds 10,995 shares of EW stock, worth $821,436. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,995
Previous 15,537 29.23%
Holding current value
$821,436
Previous $1.03 Million 20.68%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025
SELL
$64.54 - $75.92 $293,140 - $344,828
-4,542 Reduced 29.23%
10,995 $813,000
Q3 2024

Nov 04, 2024
SELL
$59.7 - $93.78 $700,161 - $1.1 Million
-11,728 Reduced 43.01%
15,537 $1.03 Million
Q2 2024

Aug 05, 2024
SELL
$84.3 - $94.31 $30,432 - $34,045
-361 Reduced 1.31%
27,265 $2.52 Million
Q1 2024

May 03, 2024
BUY
$72.54 - $95.56 $1.3 Million - $1.71 Million
17,903 Added 184.13%
27,626 $2.64 Million
Q4 2023

Feb 05, 2024
SELL
$61.71 - $77.76 $29,127 - $36,702
-472 Reduced 4.63%
9,723 $741,000
Q3 2023

Nov 06, 2023
SELL
$69.28 - $93.38 $10,461 - $14,100
-151 Reduced 1.46%
10,195 $706,000
Q2 2023

Aug 04, 2023
BUY
$81.41 - $94.33 $13,025 - $15,092
160 Added 1.57%
10,346 $975,000
Q1 2023

May 02, 2023
SELL
$74.26 - $84.51 $12,995 - $14,789
-175 Reduced 1.69%
10,186 $842,000
Q4 2022

Feb 06, 2023
SELL
$68.3 - $87.44 $1,775 - $2,273
-26 Reduced 0.25%
10,361 $773,000
Q3 2022

Oct 28, 2022
SELL
$82.37 - $107.29 $49,916 - $65,017
-606 Reduced 5.51%
10,387 $858,000
Q2 2022

Jul 22, 2022
BUY
$86.5 - $128.27 $10,985 - $16,290
127 Added 1.17%
10,993 $1.05 Million
Q1 2022

May 05, 2022
BUY
$101.96 - $128.34 $12,541 - $15,785
123 Added 1.14%
10,866 $1.28 Million
Q4 2021

Feb 08, 2022
BUY
$106.37 - $130.68 $351,340 - $431,636
3,303 Added 44.4%
10,743 $1.39 Million
Q3 2021

Nov 12, 2021
BUY
$102.91 - $122.75 $37,562 - $44,803
365 Added 5.16%
7,440 $842,000
Q2 2021

Aug 04, 2021
BUY
$83.84 - $104.76 $6,371 - $7,961
76 Added 1.09%
7,075 $733,000
Q1 2021

May 04, 2021
SELL
$78.68 - $90.67 $6,215 - $7,162
-79 Reduced 1.12%
6,999 $585,000
Q4 2020

Feb 03, 2021
SELL
$71.69 - $91.23 $44,089 - $56,106
-615 Reduced 7.99%
7,078 $646,000
Q3 2020

Nov 04, 2020
BUY
$67.19 - $87.44 $5,039 - $6,558
75 Added 0.98%
7,693 $614,000
Q2 2020

Aug 11, 2020
BUY
$57.54 - $76.95 $306,458 - $409,835
5,326 Added 232.37%
7,618 $526,000
Q1 2020

Apr 30, 2020
BUY
$52.41 - $81.0 $72,378 - $111,861
1,381 Added 151.59%
2,292 $432,000
Q4 2019

Jan 31, 2020
BUY
$71.7 - $82.09 $65,318 - $74,783
911 New
911 $213,000

Others Institutions Holding EW

# of Institutions
1,379
Shares Held
485M
Call Options Held
6.71M
Put Options Held
3.17M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $46.2B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email